ERYTECH PHARMA (EPA:ERYP) ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer
Transparency directive : regulatory news
14/01/2021 22:30
Tweeter
ERYTECH Announces First Patient Enrolled in...
14/01/2021 22:30
ERYTECH to Present at the H.C. Wainwright...
06/01/2021 22:30
ERYTECH Completes Enrollment in TRYbeCA-1 ...
14/12/2020 22:30
ERYTECH to Present at the JMP...
10/12/2020 22:30
ERYTECH Announces Positive Results from...
07/12/2020 08:00
ERYTECH Announces Conference Webcast to...
03/12/2020 22:30
Monthly information related to total number...
06/08/2020 18:00
Monthly information related to total number...
10/07/2020 18:00
ERYTECH extends its cash horizon by...
25/06/2020 08:00
Erytech’s Combined Shareholders’ Meeting
26/05/2020 22:00
Read all communications published by the company